|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization expenses | |||||
| Amortization of premiums and accretion of discounts associated with investments, net | |||||
| (Gains) losses on investments and from sales of businesses, net | |||||
| (Gains) losses on derivatives, net | |||||
| (Income) loss from equity method investments, net of dividends or distributions | |||||
| Interest credited to policyholder account balances | |||||
| Universal life and investment-type product policy fees | |||||
| Change in contractholder-directed equity securities and fair value option securities | |||||
| Change in accrued investment income | |||||
| Change in premiums, reinsurance and other receivables | |||||
| Change in market risk benefits | |||||
| Change in deferred policy acquisition costs and value of business acquired, net | |||||
| Change in income tax | |||||
| Change in other assets | |||||
| Change in insurance-related liabilities and policy-related balances | |||||
| Change in other liabilities | |||||
| Other, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Sales, maturities and repayments of fixed maturity securities available-for-sale | |||||
| Sales, maturities and repayments of equity securities | |||||
| Sales, maturities and repayments of mortgage loans | |||||
| Sales, maturities and repayments of real estate and real estate joint ventures | |||||
| Sales, maturities and repayments of other limited partnership interests | |||||
| Sales, maturities and repayments of short-term investments | |||||
| Purchases of fixed maturity securities available-for-sale | |||||
| Purchases of equity securities | |||||
| Purchases of mortgage loans | |||||
| Purchases of real estate and real estate joint ventures | |||||
| Purchases of other limited partnership interests | |||||
| Purchases of short-term investments | |||||
| Cash received in connection with freestanding derivatives | |||||
| Cash paid in connection with freestanding derivatives | |||||
| Sales of businesses | |||||
| Purchases of businesses (net of cash received of $172, $0 and $0, respectively) | |||||
| Payments to Acquire Interest in Joint Venture | |||||
| Net change in policy loans | |||||
| Net change in other invested assets | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Policyholder account balances - deposits | |||||
| Policyholder account balances - withdrawals | |||||
| Net change in payables for collateral under securities loaned and other transactions | |||||
| Cash paid for other transactions with tenors greater than three months | |||||
| Long-term debt issued | |||||
| Long-term debt repaid | |||||
| Collateral financing arrangement repaid | |||||
| Subordinated debt securities issued | |||||
| Derivatives with certain financing elements and other derivative-related transactions, net | |||||
| Proceeds from mortgage loan secured financing | |||||
| Repayments of mortgage loan secured financing | |||||
| Treasury stock acquired in connection with share repurchases | |||||
| Redemption of preferred stock | |||||
| Preferred stock redemption premium | |||||
| Dividends on preferred stock | |||||
| Dividends on common stock | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of change in foreign currency exchange rates on cash and cash equivalents balances | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, including subsidiaries held-for-sale, beginning of year | |||||
| Cash and cash equivalents, including subsidiaries held-for-sale, end of year | |||||
| Cash and cash equivalents, subsidiaries held-for-sale, beginning of year | |||||
| Cash and cash equivalents, subsidiaries held-for-sale, end of year | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Net cash paid for Interest | |||||
| Net cash paid (received) for Income tax | |||||
| Non-cash transactions: | |||||
| Funds withheld liabilities established in connection with reinsurance transactions | |||||
| Fixed maturity securities available-for-sale disposed of in connection with a reinsurance transaction | |||||
| Fixed maturity securities available-for-sale received in connection with pension risk transfer transactions | |||||
| Operating lease liability associated with the recognition of right-of-use assets | |||||
| Equity securities received due to in-kind distributions from other limited partnership interests | |||||
| Other invested assets reclassified to contractholder-directed equity securities and fair value option securities | |||||
| Mortgage loans disposed of in connection with a reinsurance transaction | |||||
| Real estate and real estate joint ventures acquired in satisfaction of debt | |||||
| Short-term investments received in connection with pension risk transfer transactions | |||||
| Other invested assets received in connection with the sale of other limited partnership interests | |||||
| Increase in real estate and real estate joint ventures | |||||
| Increase in short-term debt | |||||
Loading...